11 October, 2023 Allgemein New article alert: “The PTXΔLNP® Platform: On the Promise of Developing New LNPs for Tomorrow’s mRNA Therapies”.
07 June, 2023 Allgemein Pantherna Therapeutics teams up with University Medicine Rostock (UMR) on exploring new opportunities for mRNA therapy in ocular disease
04 October, 2022 Allgemein Astellas and Pantherna Enter into a New Technology Evaluation Agreement for Research with Expanded Target Organ to Generate mRNA-Based Regenerative Medicine Programs Using Direct Reprogramming
05 September, 2022 Allgemein Pantherna Therapeutics collaborates with Charité – Universitätsmedizin Berlin to investigate the potential of therapeutic mRNA in autoimmune disease
11 January, 2022 Uncategorized Pantherna Therapeutics secures EUR 4.0 Mio. follow-on financing to advance its therapeutic mRNA development programs
15 November, 2021 Allgemein Astellas and Pantherna Enter into Technology Evaluation Agreement for Research of mRNA-based Regenerative Medicine.
